Cyclacel Pharmaceuticals CYCCP

Annual report 2024
added 11-26-2025

Cyclacel Pharmaceuticals DIO Ratio 2011-2026 | CYCCP

Annual DIO Ratio Cyclacel Pharmaceuticals

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	-	-	-	-	-	-	-	185

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
185	185	185

DIO Ratio of other stocks in the Biotechnology industry

	Issuer	DIO Ratio	Price	% 24h	Market Cap	Country
	Acorda Therapeutics ACOR	345	-	-24.86 %	$ 820 K	USA
	Acasti Pharma ACST	136	-	4.01 %	$ 150 M	Canada
	Alexion Pharmaceuticals, Inc. ALXN	512	-	-	$ 40.3 B	USA
	Albireo Pharma ALBO	26.1	-	-0.23 %	$ 916 M	USA
	Aptorum Group Limited APM	4.89	$ 0.8	1.27 %	$ 4.36 M	China
	Midatech Pharma plc MTP	40.6	-	-18.52 %	$ 27.3 M	Britain
	Институт стволовых клеток человека ISKJ	275	-	-	-	Russia
	Aeterna Zentaris AEZS	55.6	-	5.93 %	$ 314 M	Canada
	BioCardia BCDA	4.08	$ 1.36	7.09 %	$ 28.8 M	USA
	Anika Therapeutics ANIK	247	$ 14.64	1.92 %	$ 215 M	USA
	AVEO Pharmaceuticals AVEO	63.8	-	-	$ 521 M	USA
	Aytu BioScience AYTU	209	$ 2.65	0.38 %	$ 16.6 M	USA
	AstraZeneca PLC AZN	206	-	-	$ 96.9 B	Britain